Cure, Inc.
Other · New York, New York
Cure, Inc. is a other company based in New York, New York, incorporated in 2017. It has reported $8.8 million raised across 7 Form D filings with the SEC, most recently in 2024.
Support Sales Email +1 646 663 8030 ✖ Solutions --> --> THE PLATFORM Unified Healthcare Platform One intelligent system. Complete clinical and financial mastery.
| Date | Round | Amount | Raised to date | Lead investor | Source |
|---|---|---|---|---|---|
| 2024-09-25 | — | $1.5M | $8.8M | SEC Form D | |
| 2023-08-25 | — | $365K | $7.3M | SEC Form D | |
| 2022-08-30 | — | $3.0M | $6.9M | SEC Form D | |
| 2021-02-01 | — | $1.0M | $3.9M | SEC Form D | |
| 2020-08-18 | — | $2.6M | $2.9M | SEC Form D | |
| 2019-07-16 | — | $25K | $305K | SEC Form D | |
| 2018-08-28 | — | $280K | $280K | SEC Form D |
SEC rows are Form D filings, where the amount is what was actually sold and amendments update a round rather than adding one. Press rows are split between company-issued releases or wires and editorial or third-party coverage. The total is therefore a floor: a round nobody reported is a round we cannot see. A buyout or control change appears in the timeline but is never added to the total: that money goes to shareholders, not into the company.
Form D is the notice a company files with the SEC when it sells securities without registering them. It reports the amount sold, not a valuation. Figures here are what the filing says. Where a filing is silent, the field is left blank rather than estimated. “Total raised” adds press-reported rounds that never appear in a filing, so it is a floor rather than an audited sum: press amounts are the figures the company announced, and a round nobody reported is a round we cannot see.